View in EDS

Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.

Saved in:
Bibliographic Details
Title: Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.
Authors: Shrestha S; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Tapper EE; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Trogstad-Isaacson CS; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA., Hobday TJ; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA., Offer SM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA., Diasio RB; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.; Mayo Clinic College of Medicine, Rochester, MN 55905 USA.; Mayo Clinic Cancer Center, Rochester, MN 55905 USA.
Source: JCO precision oncology [JCO Precis Oncol] 2018; Vol. 2. Date of Electronic Publication: 2018 Oct 03.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2473-4284 (Print) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-4284
DOI:10.1200/po.18.00179